{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T10:09:08Z","timestamp":1698401348438},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,1,1]],"date-time":"1989-01-01T00:00:00Z","timestamp":599616000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother. Pharmacol."],"published-print":{"date-parts":[[1989]]},"DOI":"10.1007\/bf00451647","type":"journal-article","created":{"date-parts":[[2004,11,15]],"date-time":"2004-11-15T18:27:55Z","timestamp":1100543275000},"page":"231-237","source":"Crossref","is-referenced-by-count":6,"title":["Exacerbation of toxic effects by endotoxin contamination of recombinant human tumor necrosis factor"],"prefix":"10.1007","volume":"23","author":[{"given":"Yukio","family":"Ozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Oyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoji","family":"Kume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF02023142","volume":"177","author":"B Behrens","year":"1935","unstructured":"Behrens B, Karber G (1935) Wie sind Reihenversuche f\u00fcr biologische auswertungen am zweckm\u00e4\u00dfigsten anzuordnen? Arch Exp Pathol Pharmakol 177:379","journal-title":"Arch Exp Pathol Pharmakol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.3895437","volume":"30","author":"B Beutler","year":"1985","unstructured":"Beutler B, Milsark IW, Cerami AC (1985) Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 30:869?871","journal-title":"Science"},{"key":"CR3","first-page":"2986","volume":"47","author":"M Blick","year":"1987","unstructured":"Blick M, Sherwin SA, Rosenblum M, Gutterman J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47:2986?2989","journal-title":"Cancer Res"},{"key":"CR4","first-page":"165","volume":"25","author":"N bloksma","year":"1987","unstructured":"bloksma N, Hofhuis FMA (1987) Synergistic action of human recombinant tumor necrosis factor with endotoxins or nontoxic poly A:U against solid Meth A tumors in mice. Cancer Immunol Immunother 25:165?171","journal-title":"Cancer Immunol Immunother"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1073\/pnas.72.9.3666","volume":"72","author":"EA Carswell","year":"1975","unstructured":"Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72:3666?3670","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1084\/jem.164.6.2113","volume":"164","author":"MA Collart","year":"1986","unstructured":"Collart MA, Belin D, Bassalli J-D, de Kossodo S, Vassalli P (1986) g-Interferon enhances macrophage transcription of the tumor necrosis factor\/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors. J Exp med 164:2113?2118","journal-title":"J Exp med"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/jnci\/59.5.1519","volume":"59","author":"S Green","year":"1977","unstructured":"Green S, Dobrjansky A, Chiasson MA, Carswell E, Schwartz MK, Old LJ (1977) Corynebacterium parvulum as the priming agent in the production of tumor necrosis factor in the mouse. J Natl Cancer Inst 59:1519?1522","journal-title":"J Natl Cancer Inst"},{"key":"CR8","first-page":"13","volume":"128","author":"I Gresser","year":"1987","unstructured":"Gresser I, Woodrow D, Moss J, Maury C, Tavernier J, Fiers W (1987) Toxic effects of recombinant tumor necrosis factor in suckling mice. Comparisons with interferon a\/b. Am J Pathol 128:13?18","journal-title":"Am J Pathol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/dna.1986.5.157","volume":"5","author":"H Ito","year":"1986","unstructured":"Ito H, Shirai T, Yamamoto S, Akira M, Kawahara S, Todd CW, Wallace RB (1986) Molecular cloning of the gene encoding rabbit tumor necrosis factor. DNA 5:157?165","journal-title":"DNA"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00570490","volume":"20","author":"K Kimura","year":"1987","unstructured":"Kimura K et al. (19 other authors) (1987) Phase I study of recombinant human tumor necrosis factor. Cancer Chemother Pharmacol 20:223?229","journal-title":"Cancer Chemother Pharmacol"},{"key":"CR11","first-page":"553","volume":"14","author":"A Koj","year":"1987","unstructured":"Koj A, Kurdowska A, Magielska-Sero D, Rokita H, Sipe JD, Dayer JM, Demczuk S, Gauldie J (1987) Limited effects of recombinant human and murine interleukin 1 and tumor necrosis factor on production of acute phase proteins by cultured rat hepatocytes. Biochem Int 14:553?560","journal-title":"Biochem Int"},{"key":"CR12","first-page":"583","volume":"56","author":"DG Remick","year":"1987","unstructured":"Remick DG, Kunkel RG, Larrick JW, Kunkel SL (1987) Acute in vivo effects of human recombinant tumor necrosis factor. Lab Invest 56:583?590","journal-title":"Lab Invest"},{"key":"CR13","first-page":"1364","volume":"ii","author":"P Seuderi","year":"1986","unstructured":"Seuderi P, Sterling KE, Lam KS, Finley PR, Ryan KJ, Ray CG, Peterson E, Slymen D, Salmon SE (1986) Raised serum levels of tumor necrosis factor in parasitic infections. Lancet ii:1364?1365","journal-title":"Lancet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/313803a0","volume":"313","author":"T Shirai","year":"1985","unstructured":"Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB (1985) Cloning and expression in Escherichia coli of the gene for human tumor necrosis factor. Nature 313:803?806","journal-title":"Nature"},{"key":"CR15","first-page":"410","volume":"128","author":"JE Talmadge","year":"1987","unstructured":"Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard M, Liggit D (1987) Toxicity of tumor necrosis factor is synergistic with g-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol 128:410?425","journal-title":"Am J Pathol"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.3764421","volume":"23","author":"KJ Tracey","year":"1986","unstructured":"Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ III, Zentella A, Albert JD, Shires GT, Cerami A (1986) Shock and tissue injury induced by recombinant human cachectin. Science 23:470?474","journal-title":"Science"},{"key":"CR17","first-page":"415","volume":"164","author":"KJ Tracey","year":"1987","unstructured":"Tracey KJ, Lowry SF, Fahey TJ III, Albert JD, Fong Y, Hesse D, Beutler B, Manogue KR, Calvano S, Wei H, Cerami A (1987) Cachectin\/tumor necrosis factor induced lethal shock and stress hormone response in the dog. Surg Gynecol Obstetr 164:415?422","journal-title":"Surg Gynecol Obstetr"},{"issue":"Suppl 5","key":"CR18","doi-asserted-by":"crossref","first-page":"s607","DOI":"10.1093\/clinids\/9.Supplement_5.S607","volume":"9","author":"R Urbaschek","year":"1987","unstructured":"Urbaschek R, Urbaschek B (1987) Tumor necrosis factor and interleukin 1 as mediators of endotoxin-induced beneficial effects. Rev Infect Dis [Suppl 5] 9:s607-s615","journal-title":"Rev Infect Dis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-3083.1986.tb02194.x","volume":"24","author":"A Waage","year":"1986","unstructured":"Waage A, Espevik T, Lamvik J (1986) Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicemia but not from untreated cancer. Scand J Immunol 24:739?743","journal-title":"Scand J Immunol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00451647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00451647\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00451647","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T21:34:45Z","timestamp":1554327285000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00451647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989]]}},"alternative-id":["BF00451647"],"URL":"https:\/\/doi.org\/10.1007\/bf00451647","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989]]}}}